| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $219.0M | +22.0% |
| Cost of Revenue | $60.6M | +12.0% |
| Gross Profit | $158.4M | +26.4% |
| R&D Expense | $64.2M | +19.9% |
| SG&A Expense | $84.7M | +21.2% |
| Operating Income | $5.8M | +525.3% |
| Pre-tax Income | $3.2M | -51.3% |
| Income Tax | $3.8M | +52.3% |
| Net Income | -$640K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $42.2M | -53.4% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $82.9M | +12.6% |
| Current Assets | $163.9M | -20.4% |
| Total Assets | $418.7M | +32.8% |
| Current Liabilities | $71.9M | +18.7% |
| Long-term Debt | $67.0M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $24.1M | +147.9% |
| Capital Expenditures | $32.6M | +90.2% |
| Investing Cash Flow | -$137.4M | -2214.0% |
| Financing Cash Flow | $64.6M | +674.8% |
| Free Cash Flow | -$8.6M | -15.1% |
| -115.8% |
| EPS (Basic) | -$0.02 | -118.2% |
| EPS (Diluted) | -$0.02 | -120.0% |
| Total Liabilities |
| $147.7M |
| +113.2% |
| Stockholders' Equity | $271.0M | +10.2% |